785 articles
The largest epigenetic testing merger yet aims to connect biological age scores directly to personalized interventions and supplements.
An $80M renewal of the Long Life Family Study uncovers genes, proteins, and fitness traits that predict exceptional longevity.
MIT's self-organizing laser creates ultra-sharp brain images 25x faster, enabling real-time tracking of drugs crossing the blood-brain barrier.
A small Brazilian trial found 43% of women taking 2,000 IU vitamin D daily achieved complete cancer remission vs 24% on placebo.
Clinical trials test onion claims on testosterone, bone density, allergies, and cancer — results are more nuanced than headlines suggest.
New research confirms obesity causally worsens psoriasis, and GLP-1 agonists plus diet changes may improve both skin and systemic health.
New findings link poor sleep in epilepsy to dementia risk, identify three Alzheimer's decline patterns, and show how negative environments age the brain faster.
Lung cancer screening rates hit just 24.5% in 2024 — far below other cancer screenings. Here's what's driving the gap and who's most at risk.
New research shows pro-inflammatory T cells persist long after returning to normal weight, suggesting obesity's immune damage takes years to reverse.
Dasatinib and quercetin, a leading senolytic combo, unexpectedly reduced myelination in healthy mouse brains, mimicking multiple sclerosis damage.
Alnylam's ALN-4324 enters Phase 2 testing as a once-injected RNAi therapy aiming to restore insulin sensitivity in Type 2 diabetes patients.
Denali's Avlayah uses a novel transport platform to cross the blood-brain barrier, cutting CSF biomarkers by 91% in trials.
